Preclinical Studies in Adipose Tissue

In-vivo preclinical assessment of subcutaneous PK/PD profiles in healthy and disease animal models.

 

 

 

 

Our animal models include healthy and disease models (e.g., diabetes) in rodents and pigs. Preclinical in-vivo studies are performed in cooperation with the Institute for Biomedical Research at the Medical University of Graz.

We investigate intended effects of your drug and potential side effects directly in subcutaneous tissue by applying a formulated drug via the intended route (e.g. subcutaneous, oral, topical). We use adipose OFM probes in the dermis and continuously sample interstitial fluid. Multiple probes per application site allow for an efficient study design which delivers a large amount of reliable data while using only a relatively small number of subjects in PK/PD studies.

Complementary techniques include in-vivo biopsies to obtain cross-sectional PK profiles.

 

Our Services

 

  • Spatial and temporal pharmacokinetic profiles for your drug in subcutaneous adipose tissue for up to 72 hours.
  • In-vivo dose-response is measured directly in the tissue instead of surrogate parameters in blood.
  • Very early in your drug development process you can demonstrate intended therapeutic effects and the intended mechanisms of action for your API in-vivo in adipose tissue.
  • No need to formulate the API for dose-response studies.
  • Reduced costs by minimizing the risk of failure with in-vivo PK/PD data at the earliest possible stage in drug development.
  • Identical aOFM set-up in preclinical and clinical experiments ensures highly translatable results.
openflowmicroperfusion.com

More information

To learn more about our innovative technology and its application, please visit our dedicated OFM website.

Contact Us

 

Learn more about our Preclinical Study Sercices

Schedule a conversation with
our experts: croservices@joanneum.at